F-Prime Capital Partners Life Sciences Fund VIII LP

25490020CKTGSLFHNT23

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: Limited Partnership (T91T)
Jurisdiction: US-DE
Entity created: December 13, 2022

Address

Country: United States
Legal address: C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 1209 ORANGE ST19801 WILMINGTONUnited States (US-DE)
Head office: C/O IMPRESA MANAGEMENT LLC, CORPORATION TRUST CENTER, 1209 ORANGE ST19801 WILMINGTONUnited States (US-DE)

Identifier

LEI: 25490020CKTGSLFHNT23
Registered: December 19, 2024 at 03:21 PM UTC
Last updated: July 6, 2026 at 08:38 PM UTC
Next renewal: December 19, 2026 at 03:21 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 7185615
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 7185615
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

IMPRESA MANAGEMENT LLC
Fund managerUnited States549300S4RVL8X7P76R51

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/25490020CKTGSLFHNT23This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search